-transparent.png){kind=logo}
The three human non-Hodgkin lymphoma xenografts with different morphological appearance (lymphoblastic, centroblastic, centrocytic) had many common pheno- and genotypic features positivity of B-cell markers, 14q+ chromosomal abnormality, etc.). Furthermore, two lines (HT 58 and 130) expressed lambda light chain monoclonally. The third line (HT 117) showed bigenotypic rearrangement of light genes. A set of new anti-proteoglycan markers, especially anti-chondroitin sulfate mAbs made possible to individualize the xenografts.
Related Publications
L Kopper, and
A Bánkfalvi, and
R Mihalik, and
J Timár, and
T Glant
January 1986,
Acta morphologica Hungarica,
L Kopper, and
A Bánkfalvi, and
R Mihalik, and
J Timár, and
T Glant
January 1988,
Anticancer research,
L Kopper, and
A Bánkfalvi, and
R Mihalik, and
J Timár, and
T Glant
January 1990,
In vivo (Athens, Greece),
L Kopper, and
A Bánkfalvi, and
R Mihalik, and
J Timár, and
T Glant
January 1990,
Cancer immunology, immunotherapy : CII,
L Kopper, and
A Bánkfalvi, and
R Mihalik, and
J Timár, and
T Glant
August 1992,
Cancer,
L Kopper, and
A Bánkfalvi, and
R Mihalik, and
J Timár, and
T Glant
September 2008,
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
L Kopper, and
A Bánkfalvi, and
R Mihalik, and
J Timár, and
T Glant
January 2013,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
L Kopper, and
A Bánkfalvi, and
R Mihalik, and
J Timár, and
T Glant
June 2004,
International journal of cancer,
L Kopper, and
A Bánkfalvi, and
R Mihalik, and
J Timár, and
T Glant
February 2012,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
L Kopper, and
A Bánkfalvi, and
R Mihalik, and
J Timár, and
T Glant
December 2018,
Current hematologic malignancy reports,
